A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin
Salt-induced kinase 2 (SIK2) is a serine-threonine kinase that regulates centrosome splitting, activation of PI3 kinase and phosphorylation of class IIa HDACs, affecting gene expression. Previously, we found that inhibition of SIK2 enhanced sensitivity of ovarian cancer cells to paclitaxel. Carbopla...
Main Authors: | Dengxuan Fan, Hailing Yang, Weiqun Mao, Philip J. Rask, Lan Pang, Congjian Xu, Hariprasad Vankayalapat, Ahmed A. Ahmed, Robert C. Bast, Zhen Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/3/446 |
Similar Items
-
Analysis of Adaptive Olaparib Resistance Effects on Cisplatin Sensitivity in Triple Negative Breast Cancer Cells
by: Ambikai Gajan, et al.
Published: (2021-07-01) -
Research progress on biodosimeters of ionizing radiation damage
by: Changyan Xiao, et al.
Published: (2020-09-01) -
M2 Macrophagy-derived exosomal miRNA-5106 induces bone mesenchymal stem cells towards osteoblastic fate by targeting salt-inducible kinase 2 and 3
by: Yuan Xiong, et al.
Published: (2020-04-01) -
Valproic Acid-Mediated Reduction of DNA Double-Strand Break Reparation Capacity of Irradiated MCF-7 Cells
by: Ahmad yarmohamadi, et al.
Published: (2016-12-01) -
Cytotoxic and targeted therapy for BRCA1/2-driven cancers
by: Evgeny N. Imyanitov
Published: (2021-08-01)